Early-Phase Trials in
            <i>Journal of Clinical Oncology</i>

Thomas E. Stinchcombe; Gini F. Fleming; Charles Craddock; Andrew H. Ko; Eileen M. O'Reilly; Robert G. Maki

doi:10.1200/jco-25-00548

Early-Phase Trials in <i>Journal of Clinical Oncology</i>

T Thomas E. Stinchcombe G Gini F. Fleming (University of Chicago Medicine, Chicago, IL) C Charles Craddock A Andrew H. Ko (UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA) E Eileen M. O'Reilly (Memorial Sloan Kettering Cancer Center, New York City, NY) R Robert G. Maki (Memorial Sloan Kettering Cancer Center, New York, NY)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Journal of Clinical Oncology

Volume / Issue Vol. 43, Issue 19

Published July 01, 2025

Pages 2139-2141

DOI 10.1200/jco-25-00548

ISSN 0732-183X

Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

T

Thomas E. Stinchcombe

G

Gini F. Fleming

University of Chicago Medicine, Chicago, IL

C

Charles Craddock

A

Andrew H. Ko

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

E

Eileen M. O'Reilly

Memorial Sloan Kettering Cancer Center, New York City, NY

R

Robert G. Maki

Memorial Sloan Kettering Cancer Center, New York, NY

Early-Phase Trials in <i>Journal of Clinical Oncology</i>

Article Details

Journal Info

Authors (6)

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer